Sun Life Financial (SLF) Earnings Date & Reports

Key Takeaways

• Sun Life Financial (SLF) is scheduled to report third-quarter 2026 results on November 4, 2026, after the market close, followed by an earnings call the next morning.
• Consensus estimates point to earnings per share (EPS) of about $1.45 (U.S. dollars), up from $1.35 in the same quarter a year earlier.
• In Canadian-dollar terms, analysts expect underlying EPS near CAD 2.03, compared with CAD 1.86 in Q3 2025.
• Sun Life has topped consensus EPS in seven of its last eight quarters, raising the bar heading into this report.
• Investors will focus on underlying return on equity (ROE), capital strength, and momentum across its asset management and insurance businesses.

Earnings Context and Why It Matters

Sun Life Financial is one of Canada's largest insurers and a growing global asset manager, with operations spanning Canada, the United States, and Asia. Its diversified model means quarterly results are closely watched as a barometer for both insurance underwriting trends and fee-based wealth businesses. The company's most recent report, Q2 2026, delivered double-digit underlying net income growth, a 19.1% underlying ROE, and strong sales momentum in health and protection products. With a consistent record of topping expectations, the upcoming Q3 release will test whether that momentum is durable amid shifting interest rates and currency moves, making it a key signal for shareholders and sector watchers alike.

Earnings Expectations

Wall Street's consensus estimate for Sun Life's Q3 2026 EPS stands at approximately $1.45 per share, according to MarketBeat and Earnings Whisper data, implying roughly 7% growth from the $1.35 reported in Q3 2025. In Canadian dollars, which Sun Life uses for its headline underlying results, analysts polled by Yahoo Finance project underlying EPS of about CAD 2.03, up from CAD 1.86 a year earlier.

Revenue estimates are less uniform because insurers report premiums, investment income, and fees in different ways. MarketBeat lists a consensus revenue figure near $987 million for the quarter, though top-line projections vary considerably by data provider and metric.

Beyond the headline numbers, analysts will scrutinize a handful of key metrics. These include underlying ROE, the Life Insurance Capital Adequacy Test (LICAT) ratio—a measure of an insurer's capital adequacy—and the contractual service margin (CSM), which reflects the future profit expected from in-force insurance business. Assets under management (AUM), net flows in the asset management arm, and insurance sales growth in Canada and Asia are also central to the story.

Sun Life has historically reacted modestly around its reports. It beat the $1.39 consensus by $0.07 in Q2 2026, yet the shares showed only a muted response, underscoring that the quality of results and forward guidance often matter more than a simple EPS beat.

AI Screener

Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and broader market opportunities more efficiently than manual screening. Whether you are tracking earnings season or evaluating long-term holdings, the AI Screener offers a structured way to surface ideas that match your criteria.

Market Reaction and Investor Sentiment

Sentiment heading into the Q3 report is broadly constructive, reflecting Sun Life's steady execution and its history of beating estimates. Management has reiterated medium-term goals of roughly 10% annual EPS growth and a 20% underlying ROE, which has kept investor expectations anchored on continued progress. Still, the stock can be sensitive to factors beyond headline earnings, including foreign exchange translation, interest-rate assumptions, and morbidity and mortality experience in its insurance lines.

Key risk factors to watch include currency headwinds from a weaker Canadian dollar, variability in U.S. dental results as the company exits Medicaid, and ongoing net outflows at its MFS investment-management affiliate amid broader pressure on active U.S. equity managers. A shortfall in any of these areas could temper the market's otherwise favorable view.

Forward Outlook and Key Factors to Monitor

Looking beyond the November report, investors should watch several themes that will shape Sun Life's trajectory in the quarters ahead.

First, capital generation and shareholder returns remain central. Sun Life has consistently generated organic capital above its 30% to 40% guidance range and has been active with dividends and share repurchases. Sustaining a strong LICAT ratio while returning capital will be an important signal of financial flexibility.

Second, the asset management business is evolving. SLC Management has completed its first full quarter as a unified platform, and management has outlined ambitions for operating margins to exceed 30% in the near term and reach the mid-30% range within five years. Progress on fundraising, deployment in private credit, and expense discipline will be closely tracked.

Third, watch the U.S. dental segment as Sun Life exits Medicaid. Management has indicated it expects the business to recover over the next one to two years, so commentary on the pace of that turnaround will matter.

Finally, currency and interest-rate dynamics will continue to influence reported results. Given the scale of Sun Life's international footprint, foreign exchange translation and shifting rate expectations can move both earnings and book value, making management's outlook on these variables a key focus for investors.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations